APR 24, 2019 5:14 PM PDT

Nanomachine Improves Drug Delivery for Cancer Therapeutics

WRITTEN BY: Nouran Amin

Recent studies on mice has allowed researchers to find a way to deliver specific drugs to certain parts of the body that are exceptionally difficult to access. Specifically, they created a nanomachine called Y-shaped block catiomer (YBC) that can bind to certain therapeutic materials forming a package of 18 nanometers wide—small enough to pass through the tight barriers in cancers of the brain or pancreas. The studies could ultimately advance the fight against cancer.

Learn about nucleic acids:

Although there are other promising treatments for cancer, such as gene therapy, which involves the injection of a nucleic acid-based drug into the bloodstream -- typically small interfering RNA (siRNA) – the nucleic acid needs to be protected within a nanoparticle or it can degrade before reaching its target.

"siRNA can switch off specific gene expressions that may cause harm. They are the next generation of biopharmaceuticals that could treat various intractable diseases, including cancer," explained Associate Professor Kanjiro Miyata of the University of Tokyo, who jointly supervised the study. "However, siRNA is easily eliminated from the body by enzymatic degradation or excretion. Clearly a new delivery method was called for."

The Y-shaped block catiomer is two component molecules of polymeric materials connected in a Y-shape. It has several sites of positive charge that bind to negative charges in siRNA.

Laser scanning microscope images of blood vessels in a mouse following treatment. Credit: © 2019 Kanjiro Miyata

"We used polymers to fabricate a small and stable nanomachine for the delivery of siRNA drugs to cancer tissues with a tight access barrier," said Miyata. "The shape and length of component polymers is precisely adjusted to bind to specific siRNAs, so it is configurable. The most surprising thing about our creation is that the component polymers are so simple, yet uPIC is so stable. It has been a great but worthy challenge over many years to develop efficient delivery systems for nucleic acid drugs. It is early days, but I hope to see this research progress from mice to help treat people with hard-to-treat cancers one day."

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 19, 2019
Cell & Molecular Biology
NOV 19, 2019
New Insight Into Chronic Pain May Help Create Novel Therapeutics
Acute pain can progress to chronic pain, which can cause other problems including depression, loss of motivation and sensory dysfunction....
DEC 06, 2019
Health & Medicine
DEC 06, 2019
Federal Restrictions Make It Hard For Cannabis Researchers
With marijuana use becoming more popular in aiding health, scientists race to find clarity around its health benefits and risks. Since the legalization of...
DEC 08, 2019
Genetics & Genomics
DEC 08, 2019
Finding a Way to Treat Dangerous Protein Aggregates
The scientists are hopeful that this work will lead to new therapeutics for neurodegenerative disease....
DEC 25, 2019
Drug Discovery & Development
DEC 25, 2019
New Drug to Make Breast Cancer Treatment More Affordable
The US Food and Drug Administration has granted accelerated approval to new breast cancer drug, trastuzumab deruxtecan. The drug’s increasing recogni...
DEC 23, 2019
Drug Discovery & Development
DEC 23, 2019
Eye Solution Approved for Surgical Application
As announced by the Dutch Ophthalmic Research Center in a press release, a new eye solution was recently approved by the US Food and Drug Administration fo...
DEC 27, 2019
Drug Discovery & Development
DEC 27, 2019
Acne Drug Linked to 10 Suicides
UK regulators claim to have found a link between at least ten suicides and a powerful acne drug, manufactured under the names Roaccutane and Accutane. Alth...
Loading Comments...